MAUNA KEA TECHNOLOGIES (EPA:MKEA) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases MAUNA KEA TECHNOLOGIES

Home
Companies
MAUNA KEA TECHNOLOGIES

BRIEF

published on 11/20/2024 at 18:53, 16 hours 3 minutes ago

End of the liquidity contract between Mauna Kea Technologies and Gilbert Dupont

Securities Liquidity Contract Termination Gilbert Dupont Mauna Kea
BRIEF

published on 11/13/2024 at 12:21, 7 days 22 hours ago

Mauna Kea Technologies: Review of recent developments

Funding Mauna Kea Technologies Cellvizio CellTolerance Food Intolerances
PRESS RELEASE

published on 11/13/2024 at 12:16, 7 days 22 hours ago

Inside Information / Other news releases
Mauna Kea Technologies provides an update on recent developments including the launch of its CellTolerance program for food intolerances and strategic initiatives to strengthen its financial structure and commercialize innovative solutions

Financial Structure Update Commercialization Mauna Kea Technologies CellTolerance Program
BRIEF

published on 10/17/2024 at 08:05, 1 month 4 days ago

Mauna Kea Technologies Shows Positive Clinical Results for Cellvizio in IBS

Clinical Study Mauna Kea Technologies Cellvizio IBS Management Gut Barrier Dysfunction
PRESS RELEASE

published on 10/17/2024 at 08:00, 1 month 4 days ago

Inside Information / Other news releases
Mauna Kea Technologies announces new positive clinical results for Cellvizio in food intolerance at UEG Week 2024, highlighting the value of Confocal Laser Endomicroscopy in managing IBS patients

IBS Mauna Kea Technologies Cellvizio Clinical Results Food Intolerance
BRIEF

published on 10/04/2024 at 17:50, 1 month 16 days ago

Evolution of the share capital and voting rights of Mauna Kea Technologies

Share Capital Voting Rights Euronext Growth Mauna Kea Technologies PACEO Financing
PRESS RELEASE

published on 10/04/2024 at 17:45, 1 month 16 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Mauna Kea Technologies reports monthly update on voting rights and shares. New shares issued under PACEO financing facility. Company specializes in real-time cellular imaging for medical diagnosis

Voting Rights Shares Medical Device Mauna Kea Technologies Cellvizio Platform
BRIEF

published on 07/17/2024 at 17:50, 4 months 3 days ago

Half-year review of the Mauna Kea Technologies liquidity contract

Liquidity Contract Actions Gilbert Dupont Mauna Kea Technologies First Half Of 2024
BRIEF

published on 05/17/2024 at 17:50, 6 months 3 days ago

Mauna Kea Technologies publishes total voting rights and capital as of April 30, 2024

Share Capital Voting Rights Euronext Growth Financial Regulation Mauna Kea Technologies
PRESS RELEASE

published on 05/17/2024 at 17:45, 6 months 3 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Mauna Kea Technologies discloses monthly information on voting rights and shares comprising share capital per Article L233-8-II of Commercial Code and Article 223-16 of AMF Regulations

Share Capital Voting Rights AMF Regulations Mauna Kea Technologies Cellvizio Platform

Accesswire

Published on 11/21/2024 at 10:03, 53 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 56 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 56 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 21 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 31 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 26 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 51 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 54 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 56 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 56 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 58 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 36 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE